KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology

总体摘要 在多PI领导下，我们建立了科学和导师合作的记录， 提出一个全面的洛杉矶大都市区为基础的跨学科研究生和研究生 高级研究培训（KUH-Advanced Research Training，简称KUH-ART）。该计划的总体目标是 是培养学员在良性肾脏病学，泌尿学， 和血液学。为了实现这一目标，我们将： 1)招收优秀、多元化的博士前、博士后研究生。我们将通过多种渠道 媒体和方案，以学生和学员在各级，全国范围内，并通过奖学金匹配 计划在KUH地区，突出了在KUH-ART研究空间有吸引力的机会 2)开发和支持个性化的指导计划，将感兴趣的学员与研究相匹配 导师和实验室我们将提供（a）易于访问的一般指导支持和学员宣传，（B） 职业指导和一般研究职业技能（手稿和赠款准备，合作，科学 （c）通过与UCLA-CTSI下的现有计划建立伙伴关系， 实习生接触到从学术界到生物技术和制药的一系列可用的研究职业。 3)鼓励开发和支持面向特定教育研究的KUH内容， KUH各级学员，利用现有的研讨会系列，课程和会议。我们将 构建和发展虚拟学习环境，促进正式和非正式的互动 在我们的学员中，与导师，以及与其他类似项目的学员。发展新型 针对学员需求的教学内容。我们将促进KUH学员的参与 在更广泛的学术界，根据他们的培训水平（MSTP，研究生系列讲座 和研讨会，CTSI KL 2课程），并将KUH内容引入这些活动。 4)衡量和评估质量和结果，以评估计划的有效性。在我们的外部指导下 和内部咨询委员会，我们将使用评估过程进行持续质量改进， 课程设置、学习环境和学员成果。 KUH-ART将受益于强大的机构支持，这将使我们能够整合现有资源， 巩固富有成效的机构间关系。KUH-ART的地理足迹和基础设施 将建立在非常成功的加州大学洛杉矶分校临床和转化科学研究所，一个研究伙伴关系， 领先的当地机构：加州大学洛杉矶分校，雪松西奈医疗中心，查尔斯R。德鲁医科大学和 科学和港口-加州大学洛杉矶分校医学中心/伦德奎斯特生物医学创新研究所。成功 KUH-ART实施将确保洛杉矶的多样化和有才华的生物医学受训者 大都市地区的招聘和最佳培训，以帮助解决在KUH地区的重要问题。

Overall Abstract Under a multi-PI leadership with an established track record of scientific and mentorship collaboration, we propose a comprehensive Los Angeles metropolitan area-based interdisciplinary graduate and postgraduate training program (KUH-Advanced Research Training or KUH-ART). The overarching objective of this program is to prepare trainees for long-term productive careers in high-impact research in benign nephrology, urology and hematology. To achieve this goal, we will: 1) Recruit outstanding and diverse pre- and postdoctoral students. We will reach out through multiple media and programs to students and trainees at all levels, nationwide, and through fellowship matching programs in the KUH area, highlighting the attractive opportunities in the KUH-ART research space 2) Develop and support a personalized guidance program, matching interested trainees with research mentors and labs. We will provide (a) easy-to-access general mentoring support and trainee advocacy, (b) career guidance and general research career skills (manuscript and grant preparation, collaboration, scientific communication, and networking) through partnerships with existing programs under UCLA-CTSI, and (c) trainee exposure to the array of available research careers from academia to biotechnology and pharma. 3) Incentivize the development and support of specific educational research-oriented KUH content for KUH trainees at all levels, leveraging existing seminar series, courses and conferences. We will construct and evolve a virtual learning environment (VLE) that facilitates formal and informal interactions among our trainees, with mentors, and with trainees at other similar programs. We will develop new instructional content specific to the needs of our trainees. We will facilitate the participation of KUH trainees in broader scholarly communities according to their level of training (MSTP, graduate student lecture series and seminars, CTSI KL2 courses), and introduce KUH content into these activities. 4) Measure and evaluate quality and outcomes to assess program effectiveness. Guided by our external and internal advisory boards, we will use the evaluation process for continuous quality improvement in curricular offerings, the learning environment, and trainee outcomes. KUH-ART will benefit from strong institutional support that will allow us to integrate existing resources and consolidate productive interinstitutional relationships. The geographic footprint and infrastructure of KUH-ART will build on the highly successful UCLA Clinical and Translational Science Institute, a research partnership of leading local institutions: UCLA, Cedars-Sinai Medical Center, Charles R. Drew University of Medicine and Science and Harbor-UCLA Medical Center/Lundquist Institute for Biomedical Innovation. Successful implementation of KUH-ART will assure that diverse and talented biomedical trainees in the Los Angeles metropolitan area are recruited and optimally trained to contribute to solving important problems in the KUH area.